» Articles » PMID: 35721169

Structural Advances in Voltage-Gated Sodium Channels

Overview
Journal Front Pharmacol
Date 2022 Jun 20
PMID 35721169
Authors
Affiliations
Soon will be listed here.
Abstract

Voltage-gated sodium (Na) channels are responsible for the rapid rising-phase of action potentials in excitable cells. Over 1,000 mutations in Na channels are associated with human diseases including epilepsy, periodic paralysis, arrhythmias and pain disorders. Natural toxins and clinically-used small-molecule drugs bind to Na channels and modulate their functions. Recent advances from cryo-electron microscopy (cryo-EM) structures of Na channels reveal invaluable insights into the architecture, activation, fast inactivation, electromechanical coupling, ligand modulation and pharmacology of eukaryotic Na channels. These structural analyses not only demonstrate molecular mechanisms for Na channel structure and function, but also provide atomic level templates for rational development of potential subtype-selective therapeutics. In this review, we summarize recent structural advances of eukaryotic Na channels, highlighting the structural features of eukaryotic Na channels as well as distinct modulation mechanisms by a wide range of modulators from natural toxins to synthetic small-molecules.

Citing Articles

Anesthetic- and Analgesic-Related Drugs Modulating Both Voltage-Gated Na and TRP Channels.

Kumamoto E Biomolecules. 2025; 14(12.

PMID: 39766326 PMC: 11727300. DOI: 10.3390/biom14121619.


Tetrodotoxin: The State-of-the-Art Progress in Characterization, Detection, Biosynthesis, and Transport Enrichment.

Zhang X, Qiao K, Cui R, Xu M, Cai S, Huang Q Mar Drugs. 2024; 22(12).

PMID: 39728106 PMC: 11676112. DOI: 10.3390/md22120531.


3D-aligned tetrameric ion channels with universal residue labels for comparative structural analysis.

Tikhonov D, Korkosh V, Zhorov B Biophys J. 2024; 124(2):458-470.

PMID: 39696821 PMC: 11788486. DOI: 10.1016/j.bpj.2024.12.019.


Isoform-specific N-linked glycosylation of NaV channel α-subunits alters β-subunit binding sites.

Beaudoin C, Kohli M, Salvage S, Liu H, Arundel S, Hamaia S J Gen Physiol. 2024; 157(1).

PMID: 39680039 PMC: 11666101. DOI: 10.1085/jgp.202413609.


Therapeutic targeting of voltage-gated sodium channel Na1.7 for cancer metastasis.

Pukkanasut P, Jaskula-Sztul R, Gomora J, Velu S Front Pharmacol. 2024; 15:1416705.

PMID: 39045054 PMC: 11263763. DOI: 10.3389/fphar.2024.1416705.


References
1.
Scheuer T . Regulation of sodium channel activity by phosphorylation. Semin Cell Dev Biol. 2010; 22(2):160-5. PMC: 3423337. DOI: 10.1016/j.semcdb.2010.10.002. View

2.
HODGKIN A, HUXLEY A . Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J Physiol. 1952; 116(4):449-72. PMC: 1392213. DOI: 10.1113/jphysiol.1952.sp004717. View

3.
Wisedchaisri G, Tonggu L, Gamal El-Din T, McCord E, Zheng N, Catterall W . Structural Basis for High-Affinity Trapping of the Na1.7 Channel in Its Resting State by Tarantula Toxin. Mol Cell. 2020; 81(1):38-48.e4. PMC: 8043720. DOI: 10.1016/j.molcel.2020.10.039. View

4.
Kingwell K . Nav1.7 withholds its pain potential. Nat Rev Drug Discov. 2019; . DOI: 10.1038/d41573-019-00065-0. View

5.
Das S, Gilchrist J, Bosmans F, Van Petegem F . Binary architecture of the Nav1.2-β2 signaling complex. Elife. 2016; 5. PMC: 4769172. DOI: 10.7554/eLife.10960. View